Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results
    • Fortis Healthcare...

    Fortis Healthcare reports profit of Rs 78 crore for June quarter

    Farhat NasimWritten by Farhat Nasim Published On 2019-08-07T09:16:26+05:30  |  Updated On 14 Aug 2021 7:18 AM GMT

    Gross debt was reduced from Rs 1,657 crore in the first quarter of 2018-19 to Rs 1,388 crore in April-June 2019-20 reflecting a robust net debt to equity ratio of 0.14 times, Fortis Healthcare said. "Fortis today is at an inflexion point with all the building blocks in place for the next phase of growth. We have achieved the much-needed stability in the business and have witnessed an encouraging start to the fiscal year," Fortis Healthcare Chairman Ravi Rajagopal said.


    New Delhi: Fortis Healthcare on Tuesday reported a consolidated net profit of Rs 78.01 crore for the quarter ended June 30, 2019, mainly on account of robust growth in hospital and diagnostic verticals.


    The company had posted a net loss of Rs 52.80 crore in the year-ago period, Fortis Healthcare said in a filing to BSE.


    Consolidated revenue from operations stood at Rs 1,138.31 crore for the quarter under review as against Rs 1,042.04 crore in the year-ago period, it added.


    Gross debt was reduced from Rs 1,657 crore in the first quarter of 2018-19 to Rs 1,388 crore in April-June 2019-20 reflecting a robust net debt to equity ratio of 0.14 times, Fortis Healthcare said. "Fortis today is at an inflexion point with all the building blocks in place for the next phase of growth. We have achieved the much-needed stability in the business and have witnessed an encouraging start to the fiscal year," Fortis Healthcare Chairman Ravi Rajagopal said.


    Also Read: Fortis ​Healthcare divests 28 per cent stake in Mauritius-based Medical and Surgical Centre

    MD and CEO Ashutosh Raghuvanshi said, "our Q1 results signify the momentum that we continue to see in our business with both the hospital and the diagnostic business having witnessed a healthy improvement in performance". The company's liquidity position has further strengthened, and it continues to undertake various measures to improve cash flows, he added.

    https://pubads.g.doubleclick.net/gampad/ads?iu=/21687779244/clinicalkey_video_ad&description_url=[placeholder]&tfcd=0&npa=0&sz=640x480&gdfp_req=1&output=vast&unviewed_position_start=1&env=vp&impl=s&correlator=

    In a media call on the results, Raghuvanshi said the company has started the process to recover dues of Rs 445.03 crore from erstwhile promoters and entities. Fortis Hospitals, a subsidiary of Fortis Healthcare had given loan as inter-corporate loans to three entities linked to former promoters Malvinder Singh and Shivinder Singh.


    Also Read: Fortis Healthcare Case: SEBI partially modifies order against Religare Finvest
    Ashutosh Raghuvanshi BSE Fiscal year 2020 Fortis Fortis CEO fortis debt fortis financial results Fortis first quarter Fortis Healthcare Fortis MD fortis profit Fortis q1 Fortis revenue FY20 Malvinder Singh Ravi Rajagopal Shivinder Singh Singh brothers 
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X